Prasuna Paraselli

This inventor holds 22 USPTO granted patents and 23 published patent applications, plus 2 CIPO patents and 13 EPO patents. Top assignees: Vertex Pharmaceuticals, Inc., Rqx Pharmaceuticals, Inc., Novartis Ag. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Prasuna Paraselli. Retrieved from https://idiyas.com/inventor/prasuna-paraselli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 23)

% Patents Active = 81.8

CIPO Patents = 2 (Patent Applications = 17)

EPO Patents = 13 (Patent Applications = 27)

Average Co-Inventor Count = 13.3

ph-index = 7

Forward Citations = 115(Granted Patents)

Company Filing History:

14 out of 1,167

Vertex Pharmaceuticals, Inc.

patents

5 out of 6

Rqx Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12384762 - Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator (2025-08-12),

2. 12324802 - Modulators of cystic fibrosis transmembrane conductance regulator (2025-06-10),

3. 12319693 - Crystalline forms of CFTR modulators (2025-06-03),

4. 12269831 - Modulators of cystic fibrosis transmembrane conductance regulator (2025-04-08),

5. 12122788 - Process of making CFTR modulators (2024-10-22),

6. 11873300 - Crystalline forms of CFTR modulators (2024-01-16),

7. 11866450 - Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators (2024-01-09),

8. 11591350 - Modulators of cystic fibrosis transmembrane conductance regulator (2023-02-28),

9. 11584761 - Process of making CFTR modulators (2023-02-21),

10. 11453655 - Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator (2022-09-27),

11. 11186566 - Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator (2021-11-30),

12. 11072635 - Macrocyclic broad spectrum antibiotics (2021-07-27),

13. 11066417 - Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators (2021-07-20),

14. 10793547 - Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator (2020-10-06),

15. 10570115 - Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator (2020-02-25),

Title: The Innovative Journey of Prasuna Paraselli

Introduction: Prasuna Paraselli, a talented inventor based in San Diego, CA, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Prasuna Paraselli holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a background in engineering and a passion for problem-solving, Prasuna Paraselli has successfully developed cutting-edge solutions that have the potential to revolutionize various industries.

Collaborations: Throughout his career, Prasuna Paraselli has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Prasuna Paraselli's relentless pursuit of innovation and his commitment to pushing the boundaries of technology make him a true visionary in the world of inventions.

Profile summary based on public USPTO records.